BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34474097)

  • 1. Substantial gaps in evaluation and treatment of patients with hepatitis B in the US.
    Ye Q; Kam LY; Yeo YH; Dang N; Huang DQ; Cheung R; Nguyen MH
    J Hepatol; 2022 Jan; 76(1):63-74. PubMed ID: 34474097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of advanced practice providers on characteristics and quality of care of patients with chronic hepatitis B.
    Kam LY; Huang DQ; Tobias AF; Poon K; Henry L; Kwo P; Cheung R; Nguyen MH
    Aliment Pharmacol Ther; 2022 Dec; 56(11-12):1591-1601. PubMed ID: 36266768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to chronic hepatitis B treatment guideline recommendations for laboratory monitoring of patients who are not receiving antiviral treatment.
    Juday T; Tang H; Harris M; Powers AZ; Kim E; Hanna GJ
    J Gen Intern Med; 2011 Mar; 26(3):239-44. PubMed ID: 20978862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B testing, care linkage, and vaccination coverage within a registry of hepatitis C infected patients.
    Harris AM; Millman AJ; Lora M; Osinubi A; Lom J; Miller LS
    Vaccine; 2019 Apr; 37(16):2188-2193. PubMed ID: 30902481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare clinically significant hepatic events and hepatitis B reactivation occur more frequently following rather than during direct-acting antiviral therapy for chronic hepatitis C: Data from a national US cohort.
    Serper M; Forde KA; Kaplan DE
    J Viral Hepat; 2018 Feb; 25(2):187-197. PubMed ID: 28845882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis.
    Tan M; Bhadoria AS; Cui F; Tan A; Van Holten J; Easterbrook P; Ford N; Han Q; Lu Y; Bulterys M; Hutin Y
    Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):106-119. PubMed ID: 33197397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLINICAL PHASES OF CHRONIC HEPATITIS B AMONG GEORGIAN PATIENTS.
    Zakalashvili M; Butsashvili M; Zarkua J; Abzianidze T; Kamkamidze G; Metreveli D
    Georgian Med News; 2022 Jan; (322):26-29. PubMed ID: 35134754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus among hematopoietic stem cell transplant recipients: Antiviral impact in seroconversion, engraftment, and mortality in a Latin American center.
    Buzo BF; Ramos JF; Marques Rossetti RA; Salles N; Mendrone-Júnior A; Rocha V; de Seixas Santos Nastri AC
    Transpl Infect Dis; 2020 Apr; 22(2):e13243. PubMed ID: 31901206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection.
    Brahmania M; Lombardero M; Hansen BE; Terrault NA; Lok AS; Perrillo RP; Belle SH; Di Bisceglie AM; Feld JJ; Lee WM; Fried MW; Janssen HLA;
    Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2541-2551.e2. PubMed ID: 30743006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    Yalçin K; Değertekin H; Kokoğlu OF; Ayaz C
    Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment eligibility of patients with chronic hepatitis B initially ineligible for therapy.
    Nguyen NH; Nguyen V; Trinh HN; Lin B; Nguyen MH
    Clin Gastroenterol Hepatol; 2013 May; 11(5):565-71. PubMed ID: 23333662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NIH consensus development statement on management of hepatitis B.
    Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
    NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of sero-markers and non-invasive assessment of liver cirrhosis in patients with Hepatitis B virus infection in Freetown, Sierra Leone: a cross-sectional study.
    Lakoh S; Firima E; Jiba DF; Kamara MN; Gashau W; Deen GF; Adekanmbi O; Yendewa GA
    BMC Gastroenterol; 2021 Aug; 21(1):320. PubMed ID: 34372775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor Adherence to Guidelines for Treatment of Chronic Hepatitis B Virus Infection at Primary Care and Referral Practices.
    Nguyen VH; Le AK; Trinh HN; Chung M; Johnson T; Wong C; Wong C; Zhang J; Li J; Levitt BS; Nguyen HA; Nguyen KK; Henry L; Cheung R; Nguyen MH
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):957-967.e7. PubMed ID: 30326298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Undertreatment of Asian chronic hepatitis B patients on the basis of standard guidelines: a community-based study.
    Zhang S; Ristau JT; Trinh HN; Garcia RT; Nguyen HA; Nguyen MH
    Dig Dis Sci; 2012 May; 57(5):1373-83. PubMed ID: 22466077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiles of HBV DNA in a large population of Chinese patients with chronic hepatitis B: implications for antiviral therapy.
    Fung J; Seto WK; Lai CL; Yuen J; Wong DK; Yuen MF
    J Hepatol; 2011 Feb; 54(2):195-200. PubMed ID: 21056499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic hepatitis B virus (HBV) infection: usefulness of the combination of HBeAg and ALT determination to predict a high HBV-DNA level and therefore the necessity of referral to a specialist for possible antiviral treatment].
    Veldhuijzen IK; Mostert MC; Niesters HG; Richardus JH; de Man RA
    Ned Tijdschr Geneeskd; 2008 Jun; 152(25):1426-30. PubMed ID: 18624006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration.
    Hunt CM; Beste LA; Lowy E; Suzuki A; Moylan CA; Tillmann HL; Ioannou GN; Lim JK; Kelley MJ; Provenzale D
    World J Gastroenterol; 2016 May; 22(19):4732-40. PubMed ID: 27217704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.